Business Description
![4D Molecular Therapeutics Inc 4D Molecular Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BPO3.png?14)
4D Molecular Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US35104E1001
Share Class Description:
FDMT: Ordinary SharesDescription
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 37.11 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.12 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 21.62 | |||||
Beneish M-Score | 8.33 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37 | |||||
3-Year EBITDA Growth Rate | 31.7 | |||||
3-Year EPS without NRI Growth Rate | 33.6 | |||||
3-Year FCF Growth Rate | 37.1 | |||||
3-Year Book Growth Rate | -9.4 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.88 | |||||
9-Day RSI | 31.64 | |||||
14-Day RSI | 35.78 | |||||
6-1 Month Momentum % | 18.51 | |||||
12-1 Month Momentum % | 35.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 32.65 | |||||
Quick Ratio | 32.65 | |||||
Cash Ratio | 32.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.3 | |||||
Shareholder Yield % | -41.86 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -591.13 | |||||
Net Margin % | -511.23 | |||||
FCF Margin % | -388.44 | |||||
ROE % | -29.34 | |||||
ROA % | -27.12 | |||||
ROIC % | -232.8 | |||||
ROC (Joel Greenblatt) % | -371.08 | |||||
ROCE % | -32.69 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 43.3 | |||||
PB Ratio | 1.79 | |||||
Price-to-Tangible-Book | 1.79 | |||||
EV-to-EBIT | -4.72 | |||||
EV-to-EBITDA | -4.96 | |||||
EV-to-Revenue | 27.89 | |||||
EV-to-Forward-Revenue | 380.27 | |||||
EV-to-FCF | -7.18 | |||||
Price-to-Net-Current-Asset-Value | 2.12 | |||||
Price-to-Net-Cash | 2.16 | |||||
Earnings Yield (Greenblatt) % | -21.19 | |||||
FCF Yield % | -7.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FDMT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
4D Molecular Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 20.452 | ||
EPS (TTM) ($) | -2.44 | ||
Beta | 3.08 | ||
Volatility % | 100.55 | ||
14-Day RSI | 35.78 | ||
14-Day ATR ($) | 1.331751 | ||
20-Day SMA ($) | 23.21825 | ||
12-1 Month Momentum % | 35.62 | ||
52-Week Range ($) | 9.44 - 36.25 | ||
Shares Outstanding (Mil) | 51.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
4D Molecular Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
4D Molecular Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
4D Molecular Therapeutics Inc Frequently Asked Questions
What is 4D Molecular Therapeutics Inc(FDMT)'s stock price today?
The current price of FDMT is $21.01. The 52 week high of FDMT is $36.25 and 52 week low is $9.44.
When is next earnings date of 4D Molecular Therapeutics Inc(FDMT)?
The next earnings date of 4D Molecular Therapeutics Inc(FDMT) is 2024-08-09 Est..
Does 4D Molecular Therapeutics Inc(FDMT) pay dividends? If so, how much?
4D Molecular Therapeutics Inc(FDMT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |